AI in Life Science Analytics Market Trends

  • Report ID: 6453
  • Published Date: Sep 19, 2024
  • Report Format: PDF, PPT

AI in Life Science Analytics Market Trends

Growth Drivers

  • AI in drug research and development: AI is gaining widespread adoption including in the life science sector. AI algorithms integrate with various datasets including chemical structure, biological, data, and patient records, which further aids in drug differentiation and interaction at a molecular level. This is positively influencing the overall AI in life science analytics market growth as AI is opening new avenues for drug discovery and streamlining clinical trials.

    Also, by predicting issues early and optimizing trial processes, AI helps reduce the costs associated with drug development. For instance, in September 2024, Google DeepMind launched AlphaProteo the first AI system that aids researchers in drug designing and disease understanding more effectively.
  • Public and private sector investments: The growing investments from both private and public sectors are significantly influencing the adoption of AI in life sciences. Governments across the world are allocating sustainable funding to research organizations and universities for AI-related life science projects. Government agencies such as the U.S. National Institutes of Health and funding and research programs including Europe Commission’s Horizon Europe are contributing to the increasing use of AI in biomedical research and healthcare.

Challenges

  • Data security and privacy concerns: AI and ML algorithms generate vast amounts of data and ensuring the confidentiality and security of this sensitive health data is most important. Attacks from cybercriminals can lead to a loss of vital data and high-profit opportunities for end users. Even though digital technologies are offering vast opportunities the concerns related to data security and privacy are expected to hamper the overall AI in life science analytics market growth to some extent.
  • High investment costs: The development and installation of AI solutions require high investments in technology, infrastructure, and expertise that can be prohibitive for organizations running on tight budgets. AI applications need high-performance computing infrastructure and specialized hardware for processing large volumes of datasets, these hardware solutions are quite expensive to install and maintain.

AI in Life Science Analytics Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

11.8%

Base Year Market Size (2024)

USD 1.5 billion

Forecast Year Market Size (2037)

USD 6.5 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Abhishek Verma


  • Report ID: 6453
  • Published Date: Sep 19, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Expanding at a CAGR of 11.8%, the global market is expected to increase from USD 1.5 billion in 2024 to USD 6.5 billion by 2037.

Some of the leading companies are IBM Corporation, Indegene, Lexalytics, Google, Inc., and AiCure LLC.

The services segment is estimated to capture a strong 52.5% of the market share through 2037.

North America is expected to hold 44.5% of the global market share through 2037.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample